With the publication of the Delegated Act on safety features, those who manufacture, sell, or dispense medications in the European Union (EU) have until February 2019 to comply with complex new track-and-trace regulations outlined in the Falsified Medicines Directive (FMD).
Click here to read a useful summary article.
The legislation also states that all medicines must have a 'tamper evident' safety feature. One of our partners, Herma, the world's leading manufacturer of labelling machines, have a new machine specially designed to apply TE labels to medicinal products. More information is available here.
Should you wish to speak to one of our experts on what this legislation means for your production line, please call us or email email@example.com